Mucositis Drug Discovery Platform
Epistem has world recognised intestinal and oral mucositis
expertise, providing industry standard models predictive of
Specialised Analysis of Epithelial Toxicity
Epistem provides specialist epithelial tissue and stem cell
analysis to investigate the aetiology, mechanism and
prevention of epithelial toxicity.
Off target / off tissue side effects
Epistem has been continuously providing GI services since its foundation in 2000. Epistem has world recognised GI expertise that can help predict, identify the cause and devise possible mitigation strategies for GI toxicity.
Acute Radiation Syndrome (ARS)
Delayed Effects of Acute Radiation Injury (DEARE)
Epistem has provided services to NIAID, BARDA, DoD and AFRRI to evaluate potential
radioprotectors and mitigators of interest to the US national stockpile. The models are run in accordance with the FDA